Results 51 to 60 of about 101 (70)

Kidney Transplant: More than Immunological Problems. [PDF]

J Clin Med
Gelpi R, Casas A, Taco O, Sanchez-Baya M, Nassiri M, Bolufer M, Paul J, Molina M, Cañas L, Vila A, Ara J, Bover J.   +11 more
europepmc   +1 more source

Pharmacological management of obesity: Current landscape and emerging therapies. [PDF]

Indian J Pharmacol
Atal S, Agrawal C, Gupta R, Sadasivam B.
europepmc   +1 more source

Post-transplant metabolic dysregulation: Insights and implications for kidney graft survival. [PDF]

World J Nephrol
Elahi T, Ahmed S, Mubarak M.
europepmc   +1 more source

How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA. [PDF]

Nephrol Dial Transplant
Morales E, Martin WP, Bevc S, Jenssen TG, Miglinas M, Trillini M.   +5 more
europepmc   +1 more source

Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN). [PDF]

Diabetes Ther
Ji L, Chen L, Cheng Z, Lu Y, Yang Y, Fu F, Zhu Y, Jin L, Kloer IM.   +8 more
europepmc   +1 more source

Anti-Obesity Medications in Longevity and Aesthetic Medicine. [PDF]

J Clin Med
Bijoch J.
europepmc   +1 more source

Obesity and emerging intervention strategies: Mechanistic insights and novel drug targets. [PDF]

Chin Med J (Engl)
Feng X, Li S, Li J, Su Z.
europepmc   +1 more source

Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review. [PDF]

Reprod Biol Endocrinol
Duah J, Seifer DB.
europepmc   +1 more source

Current Drug Development Pipeline for MASLD and MASH: Focusing on Cardiovascular Comorbidities. [PDF]

Biomedicines
Prikhodko VA, Okovityi SV.
europepmc   +1 more source

Medical vs. Surgical Obesity Management: A Narrative Review of Efficacy, Safety, and Long-Term Outcomes. [PDF]

Cureus
Akwe J, Fongeh K, Jung S, Hall MAK, Patidar V, Shin YM.   +5 more
europepmc   +1 more source